Employing RoukenBio’s proprietary platforms, RoukenCells supplies off-the-shelf inducible IndEx-2 cell lines, advanced reporter cell lines and primary immune cell banks, providing researchers with fully characterised, ready-to-use cell products.
For tailored assay systems and broader in vitro drug discovery support, RoukenBio operates as the collaborative research partner arm, encompassing custom cell line engineering, complex immune cell assays and bioanalytical characterisation expertise.
United by a passion to make sense of complexities and overcome challenges, we apply our specialised knowledge to big-picture thinking. We will explore every option to deliver over and above for your project.
RoukenCells’ Purpose
Innovators need better in vitro models to answer critical questions earlier.
- What activation thresholds matter?
- How should we characterise mechanism of action?
- Which candidate is worth advancing and why?
RoukenCells was formed to solve this gap by enabling therapeutic developers with advanced cell engineering products. By building a portfolio of engineered cell lines and primary immune cell banks we help teams move faster, reduce ambiguity and make confident, evidence-backed decisions.
What We Do
RoukenCells provides therapeutic developers with off-the-shelf cell products. Our extensive, continually updated product portfolio includes a wide range of pre-developed cell lines and immune cell banks. Our offering includes:
How Our Products Work
Whether you're screening candidates, modelling therapeutic responses or generating deeper mechanistic insight, our cell products are designed to reduce uncertainty and help you move breakthroughs forward faster.
Our teams ensure every product is:
- Assay-ready and compatible with real-world assay workflows
- Well-documented with CoA, QC packs and banking details
- Reproducible across batches and donors